Back to company

BIOPTIMATE ApS: Financial statements 2016

CVR: 36051183

BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -12,720 and a net result of DKK 39,293. Equity amounted to DKK 99,237. The solvency ratio was 82.4%.

Gross Profit
-12,720 kr.
Profit/Loss
39,293 kr.
Equity
99,237 kr.
Total Assets
120,367 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOPTIMATE ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

BIOPTIMATE ApS publishes interim reportJul 11, 2016

BIOPTIMATE ApS has published its interim report for the period July 18, 2014 – December 31, 2015.

BIOPTIMATE ApS appoints new auditorJul 5, 2016

As of July 5, 2016, RGH af 1. november 2024 A/S has been appointed auditor of BIOPTIMATE ApS.

Auditor steps down at BIOPTIMATE ApSJul 5, 2016

As of July 5, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of BIOPTIMATE ApS.

About BIOPTIMATE ApS

BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2024, the company reported a gross profit of DKK -2,075,727 and a net result of DKK -6,367,118 compared with DKK -4,997,291 the year before. Equity amounted to DKK -3,855,665.